Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Terminated 2Completed 2Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Fatigue 5Neoplasms 2cyclopia sequence 1Sleep Wake Disorders 1Pain 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Laryngeal Diseases 1Head and Neck Neoplasms 1Glioma 1Central Nervous System Neoplasms 1Carcinoma 1Brain Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 26Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Modafinil × Clear all
NCT00267332 2018-05-07

Modafinil in Opioid Induced Sedation

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 3 Terminated
90 enrolled

Neoplasms, Pain

NCT00825227 2017-11-17

Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other Agents

Teva Branded Pharmaceutical Products R&D, Inc.

Phase 2 Terminated
10 enrolled 7 charts

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡